Evoke to acquire market access firm Navience Healthcare Solutions
Evoke parent company Huntsworth paid $24 million for the agency.
Payers
‘Less about the product and more about the patient’: Soundbites from Transforming Healthcare 2018
At MM&M’s annual conference, panelists talked about how healthcare is moving toward value-based care and accelerating innovation
Can the healthcare industry really expect to drive patient engagement?
Increasing patient engagement as a tool for improving care and outcomes has been a tough code to crack for the healthcare industry.
PBMs, drugmakers face off over copay accumulators
As with most drug pricing battles, patients yet again are caught in the crossfire.
Will PBMs take heat for high drug prices?
PBMs began by providing a huge service to payers, but in recent years, they’ve begun to suck revenue from pharma manufacturers. Will they take some heat for high drug prices?
Payers: High-deductible health plans don’t drive positive consumer behavior
As the evidence mounts that high-deductibles don’t cause patients to shop or save for healthcare, payers are taking note.
Taxpayers Need to Cough up the Cash to Keep Federal Agencies Afloat
As we continue to debate the proper size and role of government in society, cast your eyes on recent polls by Gallup and Pew that found the majority of Americans felt their income tax was fair.
CVS/Aetna Moves Healthcare M&A Beyond Cost and into Disruption
This time around the M&A moves will be much bigger in scope, promising to reconfigure the complex and fragile healthcare payer/provider/patient ecosystem.
Five things for pharma marketers to know: Wednesday, November 22, 2017
WebMD reportedly lays off 10% of workforce; Roche blocks Herceptin biosimilar with patent suit; insurers cover Collegium’s Xtampza over Purdue’s OxyContin
Five things for pharma marketers to know: Thursday, October 5, 2017
Cigna will no longer cover OxyContin; the AMA no longer supports price-fixing to lower drug prices; Gottlieb is not in favor of ‘right-to-try’ laws
